Tech Center 1600 • Art Units: 1615 1618
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19221432 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Final Rejection | Veradermics, Incorporated |
| 19308925 | AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF | Final Rejection | Deciphera Pharmaceuticals, LLC |
| 18042930 | NICLOSAMIDE PARTICLES AND USES THEREOF | Final Rejection | CRITITECH, INC. |
| 19270315 | PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE | Final Rejection | ANTECIP BIOVENTURES II LLC |
| 18008793 | ANATABINE POWDER COMPOSITIONS | Non-Final OA | PHILIP MORRIS PRODUCTS S.A. |
| 19190529 | IMMEDIATE RELEASE MULTILAYER TABLET | Final Rejection | Alkermes Pharma Ireland Limited |
| 19171169 | METHODS OF USING RADIPRODIL IN THE TREATMENT OF DISORDERS | Final Rejection | GRIN Therapeutics, Inc. |
| 18413822 | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF | Final Rejection | Boehringer Ingelheim International GmbH |
| 17991697 | OSMOTIC DRUG DELIVERY SYSTEM | Non-Final OA | Supernus Pharmaceuticals, Inc. |
| 18057119 | SOLID PHARMACEUTICAL TABLET | Final Rejection | Genexa Inc. |
| 18284981 | METHOD FOR PREPARING MICROPARTICLES CONTAINING POORLY SOLUBLE DRUGS | Non-Final OA | INVENTAGE LAB INC. |
| 18212671 | PROCESS FOR THE PREPARATION OF DRUG DELIVERY SYSTEMS HAVING A TESTOSTERONE COMPOUND PRESENT IN AN OUTER LAYER OR PART, AS WELL AS SUCH DRUG DELIVERY SYSTEMS | Non-Final OA | EB IP Hybritabs B.V. |
| 18015192 | SWELLABLE ORAL PHARMACEUTICAL COMPOSITIONS | Non-Final OA | Adare Pharmaceuticals, Inc. |
| 18010245 | FORMULATION COMPRISING DAPRODUSTAT | Non-Final OA | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED |
| 18532735 | COMPOSITIONS FOR PRE-SURGICAL NUTRITIONAL SUPPLEMENTS | Non-Final OA | TM Nutrition LLC |
| 18019856 | SOLID ORAL COMPOSITION COMPRISING CARBAMATE COMPOUND, AND PREPARATION METHOD THEREFOR | Final Rejection | SK BIOPHARMACEUTICALS CO., LTD. |
| 18559440 | LOSARTAN-CONTAINING MICRO TABLET FOR PEDIATRIC APPLICATIONS | Non-Final OA | Midas Pharma GmbH |
| 18288382 | SLEEP-REGULATING TABLET ALLOWING RELEASE BY STAGES AND PREPARATION METHOD THEREOF | Non-Final OA | OVERSEAS PHARMACEUTICALS, LTD. |
| 18001635 | Dispersible Tablet Formulations Comprising Dolutegravir | Final Rejection | ViiV Healthcare Company |
| 18001634 | Formulations | Final Rejection | ViiV Healthcare Company |
| 18276464 | A PROBIOTIC GRANULE HAVING A UNIFIED STABILIZING COATING AND A METHOD FOR THE PRODUCTION THEREOF | Non-Final OA | AMD PHARMA LTD |
| 18359973 | FAST DISSOLVING PHARMACEUTICAL COMPOSITIONS | Non-Final OA | XSPRAY PHARMA AB |
| 18064383 | FAST DISSOLVING PHARMACEUTICAL COMPOSITIONS | Final Rejection | XSPRAY PHARMA AB |
| 18273732 | STABLE EMULSIONS AND METHODS | Non-Final OA | Hemp Hunter Labs Inc. |
| 18043176 | PHARMACEUTICAL COMPOSITION COMPRISING IBRUTINIB | Final Rejection | Synthon B.V. |
| 18207099 | COMPOSITIONS AND METHODS FOR TREATING DISEASES OR DISORDERS USING EXTENDED RELEASE NITRIC OXIDE RELEASING SOLUTIONS | Non-Final OA | SaNOtize Research and Development Corp. |
| 18127214 | OSMOTIC DRUG DELIVERY IMPLANTS | Non-Final OA | LYRA THERAPEUTICS, INC. |
| 17911040 | TABLET, MEDICINE, METHODS FOR PRODUCING THESE, AND KIT | Non-Final OA | Eisai R&D Management Co., Ltd. |
| 18303789 | N-PALMITOYLETHANOLAMIDE AND MELATONIN FOR USE IN THE TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER NEUROBEHAVIORAL DISORDERS SIMILARLY ACCOMPANIED BY RESTLESSNESS, IRRITABILITY, SLEEP DISORDERS, AND POTENTIALLY STEREOTYPIES | Final Rejection | EPITECH GROUP S.P.A. |
| 18040383 | LOW MOLECULAR WEIGHT PROTEIN DEGRADERS AND THEIR APPLICATIONS | Non-Final OA | Captor Therapeutics S.A. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy